Spyre Therapeutics, Inc. (SYRE)

Stammdaten

Unternehmen

NameSpyre Therapeutics, Inc.
TickerSYRE
CIK0001636282

Branche

SIC-Code2834
BeschreibungPharmaceutical Preparations

Wertpapier

CUSIP
ISIN
TypCommon Stock
TitelSpyre Therapeutics, Inc.

Status

Zuletzt geprüft2026-03-20 22:35:13.302439

Fondsaktivität (letzte 3 Quartale)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-03-03Burrows Scott LOfficer, Chief Financial OfficerOpen Market Sale-20041.66-8,332.00-3,2%
2026-03-03Burrows Scott LOfficer, Chief Financial OfficerOpen Market Sale-2,30040.56-93,288.00-35,7%
2026-03-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-9,10042.49-386,659.00-147,8%
2026-03-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-5,90041.73-246,207.00-94,1%
2026-03-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-9,10042.49-386,659.00-147,8%
2026-03-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-5,90041.73-246,207.00-94,1%
2026-02-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-95731.82-30,451.74-11,6%
2026-02-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-14,04332.87-461,593.41-176,4%
2026-02-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-95731.82-30,451.74-11,6%
2026-02-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-14,04332.87-461,593.41-176,4%
2026-01-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-10032.39-3,239.00-1,2%
2026-01-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-12,70930.47-387,243.23-148,0%
2026-01-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-10032.39-3,239.00-1,2%
2026-01-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-2,19131.79-69,651.89-26,6%
2026-01-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-12,70930.47-387,243.23-148,0%
2026-01-02Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-2,19131.79-69,651.89-26,6%
2025-12-01Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-10,99528.73-315,886.35-120,7%
2025-12-01Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-4,00529.83-119,469.15-45,7%
2025-12-01Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-10,99528.73-315,886.35-120,7%
2025-12-01Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-4,00529.83-119,469.15-45,7%
2025-11-03Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-16,84523.66-398,552.70-152,3%
2025-11-03Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-28,15523.13-651,225.15-248,9%
2025-11-03Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-16,84523.66-398,552.70-152,3%
2025-11-03Turtle CameronDirector, Officer, Chief Executive OfficerOpen Market Sale-28,15523.13-651,225.15-248,9%
2025-09-02Burrows Scott LOfficer, Chief Financial OfficerOpen Market Sale-18,42816.26-299,639.28-114,5%

Top-Fondshalter (aktuelles Quartal)

Keine Fondsdaten für das aktuelle Quartal vorhanden.